CEO Mike O’Shea of Xcelerate, Inc., a development stage startup focused on the development of cutting-edge medtech applications, met with to discuss the recent appointment of a new board member and the acquisition of a rather sizeable patent portfolio


Leave a Reply

Your email address will not be published. Required fields are marked *